Park West Asset Management LLC's Form 4 filing
Enovix Corp (ENVX) · filed Jul 16, 2021
- Accession no.
- 0000905718-21-000932
- Filed
- Jul 16, 2021
- Trade date
- Jul 14, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $30.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Park West Asset Management LLCCIK 0001386928 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 14, 2021 | Common stock, par value $0.0001 | PPurchaseAcquired | +2,142,857 | $14.00 | +$29,999,998 | 6,442,857 | Indirect | |
| Jul 14, 2021 | Common stock, par value $0.0001 | JOtherAcquired | +6,029,768 | –F2 | – | 12,472,625 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
On July 14, 2021, pursuant to an agreement and plan of merger (the "Merger Agreement") by and among Rodgers Silicon Valley Acquisition Corp. ("RSVA"), RSVAC Merger Sub Inc., a wholly-owned subsidiary of RSVA ("Merger Sub"), and Enovix Corporation ("Enovix"), the Issuer completed its initial business combination (the "Business Combination"). Pursuant to the Merger Agreement, Merger Sub merged with and into Enovix with Enovix surviving the merger as a wholly owned subsidiary of RSVA. As a result of the Business Combination, RSVA changed its name to Enovix Corporation. In connection with the consummation of the Business Combination, each share of Enovix Series P-2 Preferred Stock, par value $0.001 per share, held in the aggregate by PWIMF and PWPI was converted into an aggregate of 6,029,768 shares of the Issuer's Common Stock.
Referenced by the price of 1 transaction in Table I.